Nanodelivery of cerebrolysin and rearing in enriched environment induce neuroprotective effects in a preclinical rat model of Parkinson’s disease
MetadataShow full item record
Rearing in enriched environment (EE) improves the recuperation in animal models of Parkinson’s disease (PD). Administration of TiO2-nanowired cerebrolysin (CBL) could represent an additional strategy to protect or repair the nigrostriatal system. This study aims to explore morphofunctional and biochemical changes in a preclinical stage of PD testing the synergistic efficiency of combining both strategies, housing in EE, and nanodelivery of CBL. Sprague-Dawley male rats receiving intrastriatally 6- hydroxydopamine after a short evolution time were segregated into CBL group (rats receiving nanowired CBL), EE group (rats housed in EE), CBL + EE group (rats housed in EE and receiving nanowired CBL), and control group (rats without additional treatment). Prodromic stage and treatment effects were characterized by the presence of motor symptoms (amphetamine- induced rotational behavior test). Tyrosine hydroxylase (TH) immunohistochemistry and Western blot (p-Akt/ Akt and p-ERK/ERK 1/2 as survival markers and caspase-3 as apoptotic marker) were performed in striatum and SN. A decrease in motor symptoms was shown by rats receiving CBL. EE monitoring cages revealed that rats from CBL + EE group showed more significant number of laps in the wheel than EE group. In SN, CBL + EE group also presented the highest neuronal density. Moreover, p-Akt/Akt and p-ERK/ERK 1/2 ratio was significant higher and caspase-3 expression was lower in CBL + EE group. In conclusion, the combination of CBL and EE provided evidence of neuoprotectiveneurorestorative mechanisms by which this combined strategy promoted morphofunctional improvement by activation of survival pathways after dopamine depletion in a preclinical model of PD. © Springer Science+Business Media, LLC 2017.
Showing items related by title, author, creator and subject.
Deleterious effects of VEGFR2 and RET inhibition in a preclinical model of Parkinson’s disease (2020) Requejo C.; Ruiz-Ortega J.A.; Bengoetxea H.; Bulnes S.; Ugedo L.; Lafuente J.V. (Humana Press Inc., 2018)
Intravenous Administration of Functionalized Magnetic Iron Oxide Nanoparticles Does Not Induce CNS Injury in the Rat: Influence of Spinal Cord Trauma and Cerebrolysin Treatment (2020) Menon P.K.; Sharma A.; Lafuente J.V.; Muresanu D.F.; Aguilar Z.P.; Wang Y.A.; Patnaik R.; Mössler H.; Sharma H.S. (Academic Press Inc., 2017)
Morphological Changes in a Severe Model of Parkinson’s Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors (2020) Requejo C.; Ruiz-Ortega J.A.; Bengoetxea H.; García-Blanco A.; Herrán E.; Aristieta A.; Igartua M.; Pedraz J.L.; Ugedo L.; Hernández R.M.; ... (Humana Press Inc., 2017)